SOX9 and melanoma: Furthermore, the RARα‐selective agonist Am580, but not RXR agonists, has also been shown to stimulate the expression of the SOX9 transcription factor in a cartilage‐derived cell line,65 various breast cancer cell lines66 and melanoma cells.67